Latest news
{{'Wed, 26 Nov 2025 08:00:00 -0500' | dateFormatUsFilter}}
Novo Nordisk files for FDA approval of a higher dose of Wegovy® injection 7.2 mg
Read more
{{'Mon, 17 Nov 2025 07:45:00 -0500' | dateFormatUsFilter}}
Novo Nordisk launches introductory self-pay offer for Wegovy® and Ozempic® for $199 per month
Read more
{{'Mon, 10 Nov 2025 08:45:00 -0500' | dateFormatUsFilter}}
Novo Nordisk's Wegovy® (semaglutide 2.4 mg) was associated with liver health-related benefits not solely based on weight loss in adult patients with MASH with liver scarring, according to a new post hoc analysis
Read more
Latest on compounded and counterfeit products and other important information about semaglutide.
Career opportunities
Here are our current job openings. If we don’t currently have an opening in your area of interest, we encourage you to create a job agent and candidate profile.